EBS · —
Newron Pharmaceuticals S.p.A. (NWRN.SW) Stock
$11.72
-4.72%
EBS: NWRN.SW
—
—
Valuation
Financials & Margins
Latest News
Kraken unleashes 20x bitcoin leverage: What traders need to know
Yahoo Finance Video · Aug 12, 2026
Credit card debt climbs to $1.26 trillion: What latest data means for consumers
Yahoo Personal Finance · Aug 12, 2026
Jordan Davis to Headline Red Bull Jukebox Texas, Bringing Fan-Powered Country Music Experience to Dallas on August 20
PR Newswire · Aug 12, 2026
MSGE Stock Breaks Out On Blowout Earnings As Concert Volumes Double
Investor's Business Daily · Aug 12, 2026
Sarah Trott Reintroduces Herself Beyond Reality TV with "From Here to Where"
PR Newswire · Aug 12, 2026
Valuation & Return Ratios
Peer Comparison
About Newron Pharmaceuticals S.p.A.
—
Newron Pharmaceuticals S.p.A. is led by CEO Stefan Weber, employs 27 people, headquartered in Bresso, IT, publicly traded since 2006.
over the past 52 weeks the stock has ranged between $6.91 and $31.85, and currently trades 63.2% below its 52-week high.
Official website: www.newron.com